CoChat

Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Abstract

The putative distinct diagnostic and pathogenic potential of aDNA-Ab subtypes, differing in their affinity or epitope specificity, was subject of several studies with controversial results. Comparing five assays, characterized by different reaction conditions and nature/source of dsDNA, we investigated the abovementioned problem in a retrospective study on 100 systemic lupus erythematosus (SLE) patients and 100 controls (other CTD, autoimmune hepatopathies). As demonstrated, only assay 3 (Farrzyme, TBS, UK) and 5 (Farr-RIA, Trinity Biotech, Ireland) are really suitable to detect primarily high avidity aDNA-Ab. Both were significantly linked to lupus nephritis (specificity 84%) and highly specific for SLE (95 and 96%). Thereby, assay 3 was found to be the first solid phase ELISA probably suitable to replace the Farr-RIA. Classical ELISAs (assay 1, Orgentec, Germany, and 2, Bindazyme, TBS, UK), detecting aDNA-Ab more or less independent from their avidity, or tests with only intermediate specificity for high avidity Ab (assay 4, ELIAdn, Sweden Diagnostics, Germany), were less specific for SLE (83, 79, 91%, respectively) and not associated with renal involvement (specificity 54-57%). At least in the patients studied here, obvious antigen-related differences could not be observed. With slight differences, all assays were suitable to monitor disease activity and therapy in SLE, agreeing with the ECLAM score in about 70-80% of cases. For lupus nephritis, aC1q-Ab are as specific as high avidity aDNA-Ab and capable to close a diagnostic gap in some cases. Thus, to enhance the specificity (up to 98%) and to consider the distinct diagnostic/pathogenic potential of aDNA-Ab subtypes in SLE, under routine clinical laboratory conditions it should be recommended to combine a sensitive screening test with a more specific second assay.

Overview

Integrity signals

Registry

Crossref · 10.1191/0961203306lu2308oa

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 35 references

Research works printed but not linked: 5

  1. Tan EM, 1982, Arthritis Rheum, 25, 271
  2. Vitali C, 1992, Clin Exp Rheumatol, 10, 541
  3. Linnemann M, 2002, Clin Lab, 48, 45
  4. Budd R, 2005, Clin Chem, 51, pA75
  5. Miehle N, 2004, From animal models to human genetics: Research on the induction and pathogenicity of autoantibodies, 350

Cited by

See all 44

Metadata

Authors
Jaekel, H.-P., Trabandt, A., Grobe, N., & Werle, E.
Affiliations
  • Dietrich Bonhoeffer Klinikum (DE)
  • Clinic of Internal Medicine, Dept of Rheumatology, Hospital Demmin, Germany
Corresponding author
Jaekel, H-P
Venue
Lupus
Published
2006-06
Volume
15
Issue
6
Pages
335-345
ISSN
  • 0961-2033 (ISSN-L)
  • 1477-0962
OpenAlex
W2119504302
Cited by
43
References
35
Citations by year
2025: 1 · 2023: 2 · 2022: 1 · 2021: 2 · 2020: 3 · 2018: 1 · 2017: 3 · 2016: 2 · 2015: 2 · 2014: 3 · 2013: 1 · 2012: 8
FWCI
1.97
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Lupus (publishedVersion)
  • PubMed (publishedVersion)
Funders
Universität Heidelberg
Topics
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
  • Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
Keywords
anti-dsDNA antibodies, anti-C1q antibodies, systemic lupus erythematosus, lupus nephritis, antibody avidity, ELISA comparison, disease activity monitoring, diagnostic specificity
MeSH terms
Adult, Antibody Affinity, Antibody Specificity, Epitopes, Antibodies, Antinuclear, Autoantigens, Connective Tissue Diseases, DNA, Enzyme-Linked Immunosorbent Assay, Female, Humans, Lupus Erythematosus, Systemic, Lupus Nephritis, Male, Predictive Value of Tests, Retrospective Studies, ROC Curve, Sensitivity and Specificity, Severity of Illness Index, Complement C1q

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis. https://app.cochat.ai/papers/10.1191/0961203306lu2308oa
The paper
Jaekel, H.-P., Trabandt, A., Grobe, N., & Werle, E. (2006). Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis. Lupus. https://doi.org/10.1191/0961203306lu2308oa

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.